Review Article
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
Table 1
Important antimalarial drugs and their developmental stages.
| Antimalarial | Year of development | Developmental phase |
| Quinine | 1820 | In clinical use | Chloroquine | 1934 | In clinical use | Proguanil | 1945 | In clinical use | Pyrimethamine | 1952 | In clinical use | Piperaquine | 1966 | In clinical use | Lumefantrine | 1967 | In clinical use | Pyronaridine | 1967 | In clinical use | Mefloquine | 1974 | In clinical use | Sulphadoxine | 1981 | In clinical use | Artemisinin | 1972 | In clinical use | Atovaquone | 1991 | In clinical use | Artefenomel | Under development | Phase 1 | DSM265 | Under development | Phase 1 | M5717 | Under development | Phase 1 | Meplazumab | Under development | Phase 1 | MMV688533 | Under development | Phase 1 | SAR441121 | Under development | Phase 1 | ZY-19489 | Under development | Phase 1 | Cipargamin | Under development | Phase 2 | DM1157 | Under development | Phase 2 | MMV390048 | Under development | Phase 2 | SJ733 | Under development | Phase 2 | Tafenoquine | Under development | Phase 2 | 5-ALA HCl with SFC | Under development | Phase 2 | Artefenomel-ferroquine | Under development | Phase 2 | Imatinib-DHA-piperaquine | Under development | Phase 2 | Methylene blue with artemether and lumefantrine | Under development | Phase 2 | Ganaplacide with LUM-SDF | Under development | Phase 3 | Artemether-lumefantrine | Under development | Phase 4 |
|
|